Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer.

Pharmacogenomics J · 2018 · PMC6151284 · PMID 29925895

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

marginally significantP =0.054so close (0.05 < p ≤ 0.1)

36.0 months, HR 2.43, 95% CI 0.83–7.15, P =0.087); in the multivariable model, the effect remained marginally significant (HR 3.01, 95% CI 0.98–9.20, P =0.054) ( Table 2 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.